Innovation in pharma

Health 10-06-2021

Time to put healthcare at the heart of the digital age

European healthcare stands at a crossroads. It is time to fully embrace AI and digital technology, argues Jan-Philipp Beck.
Antibiotics
Health 26-05-2021

Antimicrobial resistance – a silent pandemic requiring global action now

If policymakers fail to address the challenge of antimicrobial resistance they risk seeing the rise of a silent pandemic, write Stella Kyriakides and Dr Tedros Adhanom Ghebreyesus.
Coronavirus 14-09-2020

COVID-19: Time to show citizens that they can count on Europe

European citizens have been exemplary in their fight against COVID 19. They have bravely overcome an acute sanitary threat and paid the high economic, social and psychological price of the lockdown, write a group of European lawmakers.
Health 09-07-2020

Taking action on the global threat of superbugs

COVID-19 has demonstrated in a quite dramatic way the huge impact of a global threat on public health and economy. While the COVID-19 crisis took us by surprise, our world faces a silent threat that is predictable and preventable, writes Hubertus Von Baumbach, the CEO of pharmaceutical company Boehringer Ingelheim.
Coronavirus 04-05-2020

New health tools for COVID-19

How to ensure access for all to a coronavirus vaccine should be the priority for world leaders. Dr Bernard Pécoul offers five ideas leaders should consider this week as they aim to raise €7.5 billion to fund vaccine research.
Health 26-08-2019

What European patients need: a shot of some good old Belgian surrealism

In art, Belgium is internationally recognised as the land of surrealism, where reality and dreams are intertwined to offer a new perspective on the world. Life sciences is another Belgian specialty and a major historical export product, a group of authors write.
Promoted content
Health 12-12-2017

Drugs incentives have saved lives in Europe

Without strong incentives to spur continued investment in medical innovation, we cannot hope to ensure the sustainability of European healthcare systems and fulfil the promise of our great union, writes Jan Fischer.
Health 10-11-2017

EMA relocation should consider the wellbeing of all Europeans

The competition for the European Medicines Agency is not a horse race but the first concrete, effective decision the EU has to make in the wake of Brexit - and one with long-lasting consequences. A responsible yet ambitious mindset is therefore in order, writes Sandro Gozi.